Pfizer boosts pipeline with biotech tissue deal
January 16, 2008Research and Development
Pfizer will partner with German biopharmaceutical company Scil Technology to develop and commercialise a new early-stage biotech treatment for cartilage …
Stakeholders clash over European patient information
January 16, 2008Medical Communications
Stakeholders have voiced fresh fears pharma is moving towards advertising prescription medicines to consumers after the European Commission continued in …
Genentech growth to slow in 2008
January 15, 2008Sales and Marketing
The spectacular growth which has made Genentech the world's biggest biotech company is set to slow in 2008, as its …
MPs call for ban on biosimilars
January 15, 2008Sales and Marketing generics
Patients risk safety by taking biotech medicines that are similar but not the same as the branded drug, MPs have …
Sharp fall in candidates taking ABPI exam
January 15, 2008Sales and Marketing
Latest results for the mandatory ABPI medical representative exam showed a 75% pass rate, but the numbers sitting the test …
Virgin launches GP service
January 15, 2008NHS, private sector
Richard Branson’s Virgin group has launched a new business offshoot which will compete to offer GP services around England.Virgin is …
Cancer Research invests
January 15, 2008Research and Development
Cancer Research UK is investing ten million pounds in drug discovery projects at four UK universities. Project leaders at Imperial …
Europe unites with Canada on safety regulation
January 15, 2008Sales and Marketing reg, safety
European and Canadian regulators have forged a transatlantic agreement to exchange confidential information about the authorisation and safety of medicines. …
Latest news from Datamonitor
January 15, 2008Research and Development
Competitive obtains license rights for breast cancer testCompetitive Technologies has signed a license and commercialization agreement for rights to the …
Animal toxicity test set to be scrapped
January 9, 2008Research and Development
The pharmaceutical industry has made a major reduction in the number of rodents used in pre-clinical drug testing after an …
Government funds superbug nurses in every hospital
January 9, 2008C diff, NHS
Millions of pounds in extra funding is to be given to hospitals in England to appoint a team of nurses …
Government seeks 10% cut on NHS medicines bill
January 7, 2008Sales and Marketing
News that the government plans to cut the NHS medicines bill by 10% has taken UK pharma industry leaders by …
GSK claims Seretide superior to Spiriva
January 3, 2008Sales and Marketing
A new head-to-head study sponsored by GSK suggests its drug Seretide reduced the risk of dying compared to rival treatment …
Lechleiter to be new Lilly chief
January 3, 2008Sales and Marketing lilly
John Lechleiter, Lilly's current president and chief operating officer has been named as the company's next chief executive.Sidney Taurel is …
Atripla approved in Europe
January 3, 2008Sales and Marketing HIV
The first ever product to combine all the drugs HIV patients need in just one daily pill has been approved …
The Pharmafocus Interview: John Patterson
December 19, 2007Research and Development, Sales and Marketing AstraZeneca, drug development, industry relations
John Patterson is an AstraZeneca man through-and-through, having spent nearly all his working life at the company. But over the …
Delayed Galvus cleared for 2008 European launch
December 19, 2007Sales and Marketing EU, diabetes
A key European regulatory committee has approved revised labelling for Novartis' diabetes drug Galvus, paving the way for a 2008 …
Cervarix US approval delayed
December 19, 2007Research and Development, Sales and Marketing
GlaxoSmithKline's cervical cancer vaccine Cervarix has suffered a setback in the US, where regulators have refused to approve it until …
Novartis to make new round of job cuts
December 19, 2007Sales and Marketing
Novartis will cut around 2,500 jobs as part of a new streamlining programme that aims to save $1.6 billion by …
Latest content
Brenntag and dsm-firmenich expand biopharma vitamin partnership
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
